Sphera Funds Management Ltd. Oric Pharmaceuticals, Inc. Transaction History
Sphera Funds Management Ltd.
- $486 Million
- Q4 2024
A detailed history of Sphera Funds Management Ltd. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 273,213 shares of ORIC stock, worth $2.19 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
273,213
Previous 128,396
112.79%
Holding current value
$2.19 Million
Previous $1.32 Million
67.48%
% of portfolio
0.45%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding ORIC
# of Institutions
132Shares Held
67.3MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$42.3 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$38.7 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$35.5 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$35.2 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$31.3 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $317M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...